Inspection Record

Zochem ULC — Health Canada Inspection Findings

Health CanadaInspected 2022-05-24 5 findingsMaterial and supplier controlDeviation, CAPA, and investigationLaboratory and QC controlsRegulatory reporting and change control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Material and supplier control

The handling and/or storage of samples was inadequate for raw materials, drugs being processed, bulk drugs, and/or finished products.

2Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

3Laboratory and QC controls

The quality control department was not a distinct unit that functioned independently and reported to management independent of any other unit.

4Laboratory and QC controls

The handling of standard operating procedures for good manufacturing practices was inadequate. The quality control department or the designated alternate did not sign and/or date quality control decisions.

5Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-05-24. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Zochem ULC company profile — full history Health Canada documents, 2022 Go to Findings search